MoneyWorks4Me

The sales for the June 2024 quarter moved down to Rs. 332.86 millions as compared to Rs. 419.47 millions during the year-ago period.The Net Loss for the quarter ended June 2024 is Rs. -7.23 millions as compared to Net Profit of Rs. 63.50 millions of corresponding quarter ended June 2023Operating profit for the quarter ended June 2024 decreased to 17.17 millions as compared to 81.63 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 332.86 419.47 -20.65 332.86 419.47 -20.65 1524.66 1153.50 32.18
Other Income 5.05 18.69 -72.98 5.05 18.69 -72.98 35.22 32.73 7.61
PBIDT 17.17 81.63 -78.97 17.17 81.63 -78.97 146.34 189.90 -22.94
Interest 6.51 6.01 8.32 6.51 6.01 8.32 22.90 20.38 12.37
PBDT 7.21 75.62 -90.47 7.21 75.62 -90.47 123.44 169.52 -27.18
Depreciation 14.44 12.12 19.14 14.44 12.12 19.14 49.95 53.34 -6.36
PBT -7.23 63.50 -111.39 -7.23 63.50 -111.39 73.49 116.18 -36.74
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.78 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -7.23 63.50 -111.39 -7.23 63.50 -111.39 73.49 113.40 -35.19
Equity 236.56 236.56 0.00 236.56 236.56 0.00 236.56 236.56 0.00
PBIDTM(%) 5.16 19.46 -73.49 5.16 19.46 -73.49 9.60 16.46 -41.70
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..